Drug Shortage Report for SUCCINYLCHOLINE CHLORIDE INJECTION USP
| Report ID | 85107 |
| Drug Identification Number | 02422336 |
| Brand name | SUCCINYLCHOLINE CHLORIDE INJECTION |
| Common or Proper name | Succinylcholine Chloride |
| Company Name | HIKMA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | SUCCINYLCHOLINE CHLORIDE |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 20ML |
| ATC code | M03AB |
| ATC description | MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-05-28 |
| Actual start date | 2019-05-28 |
| Estimated end date | 2021-03-12 |
| Actual end date | 2021-03-12 |
| Shortage status | Resolved |
| Updated date | 2021-03-13 |
| Company comments | Product is now available at wholesalers for Hospital use only. Allocation is set at 100%-200% of historical demands based on region. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2019-05-28 | French | Compare |
| v1 | 2019-05-28 | English | Compare |